CTNNB1 and hepatocellular carcinoma: IFITM3 and SERPIND1 displayed a 2.24-fold change, while RhoA, CTNNB1, and SPINK1 showed a substantial 3.3-, 3.2-, and 3.18-fold overexpression, respectively, in HCC patients compared to cirrhosis patients.